A portable, puncture-resistant sharps container will allow you to safely dispose of needles
Onset, duration, and severity of opioid withdrawal may vary based on the specific opioid used, duration of use, timing and amount of last maternal use, and rate of elimination by the newborn
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously a mechanism that may offer more pronounced hepatic benefits than existing agents such as semaglutide or tirzepatide
It is catalysed by glutamate-cysteine ligase, historically called gamma-glutamylcysteine synthetase
All participants in the orforglipron treatment arms started the study at a dose of orforglipron 1 mg once-daily and then increased the dose in a step-wise approach at four-week intervals to their final randomized maintenance dose of 3 mg (via a 1 mg step), 12 mg (via steps at 1 mg, 3 mg and 6 mg) or 36 mg (via steps at 1 mg, 3 mg, 6 mg, 12 mg and 24 mg)